Mounjaro obesity jab authorised in UK
A diabetes medicine dubbed the “King Kong” of weight loss jabs has been approved in the UK for treating obesity.
The medicine makes you feel fuller so you eat less.
In trials, people on it have lost a fifth of their body weight and UK regulators now say it is safe and effective enough to be sold and prescribed in the UK.
It’s not yet recommended on the NHS.
Healthcare spending watchdog The National Institute for Health and Care Excellence (NICE) recently said the cost for benefit of Mounjaro may not be justified.
The NHS price of the pre-filled pens has not been made public because of commercial sensitivities.
Manufacturer Eli Lilly has been asked to submit more data for the committee to review.
